Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I Results by Westin, Jason R., Sathyanarayanan, Vishwanath, Fayad, Luis E., Nastoupil, Loretta J., Turturro, Francesco, Hagemeister, Fredrick B., Simar, Kristin A., Young, Ken H., McDonnell, Timothy J., Chuang, Hubert H, Kamil, Fazal, Feng, Lei, Davis, Eric Richard, Neelapu, Sattva S., Oki, Yasuhiro

Get full text

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience by Simar, Kristin A., Sathyanarayanan, Vishwanath, Issa, Amir K, Ahmed, Mohamed Amin, Noorani, Mansoor, Fanale, Michelle A, Oki, Yasuhiro, Hagemeister, F.B., Neelapu, Sattva S., Nastoupil, Loretta, Fowler, Nathan, Turturro, Francesco, Davis, Richard Eric, Rodriguez, Maria Alma, Wang, Michael, Feng, Lei, Young, Ken H., McDonnell, Timothy J., Pinnix, Chelsea C, Fayad, Luis E., Westin, Jason R.

Get full text